Overexpression and deregulation of MYC have been implicated in resistance to immunotherapy in other cancers, including melanoma and head and neck squamous cell carcinoma, through decreased IFNγ via JAK2 downregulation[80]. The gene discussed is JAK2; the disease is melanoma.